Upcoming Events

8th Immune Effector Cell Therapies in Multiple Myeloma Workshop

8th Immune Effector Cell Therapies in Multiple Myeloma Workshop

March 19 - 20, 2027 - Boston Marriott Long Wharf, Boston, MA

Save the date for the 8th Immune Effector Cell Therapies in Multiple Myeloma Workshop – March 19-20, 2027.

More details will be released soon!

Educational Workshop in Beijing, China

Educational Workshop in Beijing, China

April 9 - 10, 2027 - Beijing, China

Join us for a dynamic educational workshop on the diagnosis, treatment, and monitoring of plasma cell malignancies, including current practices and opportunities for improvement. This workshop will include lectures plus roundtable discussions around hot and controversial topics, featuring point-counterpoint conversations between invited speakers and local hematologists based on both challenging questions and clinical cases.

 

 

More details including registration will be shared soon.

5th Annual Workshop on Genomics and Translational Medicine

5th Annual Workshop on Genomics and Translational Medicine

July 9 - 10, 2027 - Brussels, Belgium

The 5th Annual IMS Workshop on Genomics and translational medicine will be held on July 9-10, 2027 in Brussels, Belgium.

More details will be shared soon.

24th Annual Meeting & Exposition

24th Annual Meeting & Exposition

September 29 - October 2, 2027 - New Delhi, India

Join us for the 24th International Myeloma Society (IMS) Annual Meeting in New Delhi, India, where the IMS will celebrate 40 years of advancing myeloma research and care.

 

 

More details will be shared soon.

 

IMS and Paula and Rodger Riney Foundation Translational Research Award – Applications due January 29, 2027

 IMS Career Development Award – Applications due January 29, 2027

 

Meet the recipients of the IMS Translational Research Award!

Meet the recipients of the IMS Career Development Award!

About Our Publications

As a response to the current pandemic, the International Myeloma Society Executive Committee has developed the following Recommendations for the Management of Myeloma Patients During the COVID-19 Pandemic. These recommendations include directions for caring for newly diagnosed, elderly, relapsed/refractory and clinical trial patients. Please follow as appropriate for your practice and patient needs. The International Myeloma Society remains committed to keeping patients and physicians safe while providing care and treatment under these extraordinary circumstances.

See All Publications

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated